Similar articles for PMID: 30396925

Year	Number of Results
2001	1
2003	2
2004	3
2006	1
2007	5
2008	3
2009	5
2010	6
2011	7
2012	4
2013	6
2014	11
2015	17
2016	14
2017	7
2018	5
2019	1
2020	5
2021	5
2022	6

1

CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.

Kuhara K, Tokuda K, Kitagawa T, Baron B, Tokunaga M, Harada K, Terasaki M, Uehara O, Ohta T, Takai R, Hamada JI, Kobayashi M, Shimo T, Nagayasu H, Kuramitsu Y. Kuhara K, et al. Anticancer Res. 2018 Nov;38(11):6107-6111. doi: 10.21873/anticanres.12961. Anticancer Res. 2018. PMID: 30396925

2

Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.

Tokunaga M, Baron B, Kitagawa T, Tokuda K, Kuramitsu Y. Tokunaga M, et al. Anticancer Res. 2015 Nov;35(11):6063-7. Anticancer Res. 2015. PMID: 26504030

3

Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.

Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Suenaga S, et al. Anticancer Res. 2014 Jan;34(1):141-6. Anticancer Res. 2014. PMID: 24403454

4

Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.

Nawata J, Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Baron B, Akada J, Suenaga S, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Nawata J, et al. Anticancer Res. 2014 Sep;34(9):4807-11. Anticancer Res. 2014. PMID: 25202061

5

Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.

Kuramitsu Y, Suenaga S, Wang Y, Tokuda K, Kitagawa T, Tanaka T, Akada J, Maehara S, Maehara Y, Nakamura K. Kuramitsu Y, et al. Anticancer Res. 2013 Aug;33(8):3133-6. Anticancer Res. 2013. PMID: 23898070

6

CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.

Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y, Nojima Y, Sakai R. Miyazawa Y, et al. Cancer Res. 2010 Jun 15;70(12):5136-46. doi: 10.1158/0008-5472.CAN-10-0220. Epub 2010 May 25. Cancer Res. 2010. PMID: 20501830

7

CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells.

Miura S, Hamada S, Masamune A, Satoh K, Shimosegawa T. Miura S, et al. Exp Cell Res. 2014 Feb 15;321(2):209-18. doi: 10.1016/j.yexcr.2013.12.019. Epub 2013 Dec 30. Exp Cell Res. 2014. PMID: 24384474

8

A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic cancer cells.

Islam S, Kitagawa T, Baron B, Kuhara K, Nagayasu H, Kobayashi M, Chiba I, Kuramitsu Y. Islam S, et al. Oncol Lett. 2021 Sep;22(3):654. doi: 10.3892/ol.2021.12915. Epub 2021 Jul 9. Oncol Lett. 2021. PMID: 34386076 Free PMC article.

9

High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.

Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Akada J, Tokunaga M, Nakamura K. Kuramitsu Y, et al. Anticancer Res. 2015 Jul;35(7):3861-5. Anticancer Res. 2015. PMID: 26124331

10

Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.

Suenaga S, Kuramitsu Y, Wang Y, Baron B, Kitagawa T, Akada J, Tokuda K, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K. Suenaga S, et al. Anticancer Res. 2013 Nov;33(11):4821-6. Anticancer Res. 2013. PMID: 24222118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed